| 1 | Noonan syndrome 1 | Enrichment | HRAS, MAP2K1, MAP2K2, RAF1, SOS1, SOS2 | 8.62 |
| 2 | Rasopathy | Enrichment | HRAS, MAP2K1, MAP2K2, RAF1, SOS1, SOS2 | 8.27 |
| 3 | Noonan syndrome and noonan-related syndrome | Enrichment | HRAS, MAP2K1, MAP2K2, RAF1, SOS1 | 7.86 |
| 4 | Digenic alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 6.77 |
| 5 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 | Enrichment | ACTG2, MYH11, MYLK | 6.44 |
| 6 | Visceral myopathy 1 | Enrichment | ACTG2, MYH11, MYLK | 6.04 |
| 7 | Alport syndrome 3a, autosomal dominant | Enrichment | COL4A3, COL4A4, COL4A5 | 5.78 |
| 8 | Autosomal dominant alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 5.78 |
| 9 | Alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 5.78 |
| 10 | Nephrotic syndrome | Enrichment | COL4A3, COL4A4, COL4A5, FN1, ITGA3 | 5.40 |
| 11 | Noonan syndrome 3 | Enrichment | HRAS, RAF1, SOS1 | 5.24 |
| 12 | Familial hypertrophic cardiomyopathy | Enrichment | ACTC1, MYH7, MYL2, MYL3 | 4.83 |
| 13 | Baraitser-winter cerebrofrontofacial syndrome | Enrichment | ACTB, ACTG1 | 4.72 |
| 14 | Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis | Enrichment | CLDN1, CLDN16 | 4.59 |
| 15 | Hypomagnesemia 5, renal, with or without ocular involvement | Enrichment | CLDN16, CLDN19 | 4.59 |
| 16 | Renal hypomagnesemia 5 with ocular involvement | Enrichment | CLDN16, CLDN19 | 4.59 |
| 17 | Spondyloepimetaphyseal dysplasia, strudwick type | Enrichment | COL2A1, FN1 | 4.51 |
| 18 | Spondylometaphyseal dysplasia, corner fracture type | Enrichment | COL2A1, FN1 | 4.51 |
| 19 | Ehlers-danlos syndrome, arthrochalasia type, 2 | Enrichment | COL1A1, COL1A2 | 4.51 |
| 20 | Ehlers-danlos/osteogenesis imperfecta syndrome | Enrichment | COL1A1, COL1A2 | 4.51 |
| 21 | X-linked diffuse leiomyomatosis-alport syndrome | Enrichment | COL4A5, COL4A6 | 4.51 |
| 22 | Dilated cardiomyopathy | Enrichment | ACTA1, ACTC1, MYH6, MYH7, MYL2 | 4.50 |
| 23 | Distal arthrogryposis | Enrichment | ACTA1, ACTC1, MYH3, MYL11 | 4.41 |
| 24 | Congenital myopathy 4a, autosomal dominant | Enrichment | ACTA1, MYH7, MYL2 | 4.40 |
| 25 | Hypertrophic cardiomyopathy | Enrichment | ACTC1, MYH7, MYL2, MYL3 | 4.37 |
| 26 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | ACTA2, FLNA, MYH11, MYLK | 4.33 |
| 27 | Alzheimer disease 4 | Enrichment | PSEN1, PSEN2 | 4.24 |
| 28 | Osteoporosis | Enrichment | COL1A1, COL1A2, SRC | 4.23 |
| 29 | Microcephaly | Enrichment | ACTB, ACTG1, COL4A1, CTNNB1, MAPK1, TRIO | 4.19 |
| 30 | Patent foramen ovale | Enrichment | ACTC1, FLNA, MYH6 | 4.15 |
| 31 | Kidney disease | Enrichment | COL4A3, COL4A4, COL4A5 | 4.14 |
| 32 | Familial isolated dilated cardiomyopathy | Enrichment | MYH6, MYH7, PSEN1, PSEN2 | 4.06 |
| 33 | Hematuria, benign familial, 1 | Enrichment | COL4A3, COL4A4 | 4.03 |
| 34 | High bone mass osteogenesis imperfecta | Enrichment | COL1A1, COL1A2 | 4.03 |
| 35 | Myopia | Enrichment | COL2A1, COL4A4, MYH11 | 3.87 |
| 36 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | ACTG1, MYH14, MYH9, TJP2 | 3.86 |
| 37 | Thrombocytopenia | Enrichment | ACTN1, ITGB3, SRC, WAS | 3.83 |
| 38 | Hypertension | Enrichment | COL4A4, COL4A5, MYH9 | 3.79 |
| 39 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | MYH6, MYH7, MYLK2 | 3.76 |
| 40 | Ehlers-danlos syndrome, arthrochalasia type, 1 | Enrichment | COL1A1, COL1A2 | 3.73 |
| 41 | Brain small vessel disease 1 with or without ocular anomalies | Enrichment | COL4A1, COL4A2 | 3.73 |
| 42 | Cardiofaciocutaneous syndrome 1 | Enrichment | MAP2K1, MAP2K2 | 3.73 |
| 43 | Alport syndrome 2, autosomal recessive | Enrichment | COL4A3, COL4A4 | 3.73 |
| 44 | Cardiofaciocutaneous syndrome | Enrichment | MAP2K1, MAP2K2 | 3.73 |
| 45 | Autosomal recessive alport syndrome | Enrichment | COL4A3, COL4A4 | 3.73 |
| 46 | Osteogenesis imperfecta with normal sclerae, dominant form | Enrichment | COL1A1, COL1A2 | 3.73 |
| 47 | Congenital myopathy 3 with rigid spine | Enrichment | ACTA1, MYH7 | 3.69 |
| 48 | Heart, malformation of | Enrichment | COL2A1, MAPK1, MYH6 | 3.63 |
| 49 | Intestinal pseudo-obstruction | Enrichment | ACTG2, MYH11 | 3.52 |
| 50 | Typical nemaline myopathy | Enrichment | ACTA1, CFL2 | 3.52 |
| 51 | Familial porencephaly | Enrichment | COL4A1, COL4A2 | 3.51 |
| 52 | Neuropathy, hereditary sensory and autonomic, type v | Enrichment | NGF, NTRK1 | 3.40 |
| 53 | Early-onset autosomal dominant alzheimer disease | Enrichment | PSEN1, PSEN2 | 3.40 |
| 54 | Ehlers-danlos syndrome, classic type, 1 | Enrichment | COL1A1, COL1A2 | 3.34 |
| 55 | Osteogenesis imperfecta, type i | Enrichment | COL1A1, COL1A2 | 3.34 |
| 56 | Hemorrhage, intracerebral | Enrichment | COL4A1, COL4A2 | 3.34 |
| 57 | Keratoconus | Enrichment | COL1A1, COL4A1 | 3.34 |
| 58 | Fetomaternal alloimmune thrombocytopenia 1 | Enrichment | ITGA2, ITGB3 | 3.34 |
| 59 | Classic ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2 | 3.34 |
| 60 | Osteogenesis imperfecta, type ii | Enrichment | COL1A1, COL1A2 | 3.19 |
| 61 | Anterior segment dysgenesis 5 | Enrichment | ARHGAP35, COL4A1 | 3.16 |
| 62 | Familial thoracic aortic aneurysm and dissection | Enrichment | MYH11, MYLK | 3.14 |
| 63 | Myopathy | Enrichment | ACTA1, MYH2, MYH7 | 3.10 |
| 64 | Melanocytic nevus syndrome, congenital | Enrichment | HRAS, RAF1 | 3.07 |
| 65 | Arteriovenous malformation | Enrichment | HRAS, MAP2K1 | 2.96 |
| 66 | Nephrocalcinosis | Enrichment | CLDN16, CLDN19 | 2.95 |
| 67 | Nephrolithiasis | Enrichment | CLDN16, CLDN19 | 2.95 |
| 68 | Myopathy, x-linked, with excessive autophagy | Enrichment | HRAS, MAP2K1 | 2.87 |
| 69 | Autosomal dominant macrothrombocytopenia | Enrichment | ACTN1, ITGB3 | 2.87 |
| 70 | Primary bone dysplasia | Enrichment | COL1A1, COL1A2 | 2.87 |
| 71 | Colorectal cancer | Enrichment | AKT1, CCND1, CTNNB1, SRC | 2.85 |
| 72 | Osteochondrodysplasia | Enrichment | COL1A1, COL1A2 | 2.78 |
| 73 | Lung non-small cell carcinoma | Enrichment | HRAS, MAP2K1 | 2.78 |
| 74 | Aortic aneurysm, familial thoracic 1 | Enrichment | MYH11, MYLK | 2.74 |
| 75 | Peters-plus syndrome | Enrichment | ARHGAP35, COL4A1 | 2.69 |
| 76 | Osteogenesis imperfecta, type iv | Enrichment | COL1A1, COL1A2 | 2.63 |
| 77 | Chronic kidney disease | Enrichment | COL4A4, COL4A5 | 2.63 |
| 78 | Cardiomyopathy, dilated, 1e | Enrichment | MYH7, MYL2 | 2.60 |
| 79 | Neuromuscular disease | Enrichment | ACTA1, MYH7 | 2.52 |
| 80 | Osteogenesis imperfecta, type iii | Enrichment | COL1A1, COL1A2 | 2.51 |
| 81 | Congenital myopathy | Enrichment | ACTA1, MYH7 | 2.48 |
| 82 | Centronuclear myopathy | Enrichment | ACTA1, CFL2 | 2.39 |
| 83 | Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1a | Enrichment | MYH3 | 2.35 |
| 84 | Baraitser-winter syndrome 1 | Enrichment | ACTB | 2.35 |
| 85 | Deafness, autosomal dominant 17 | Enrichment | MYH9 | 2.35 |
| 86 | Cardiomyopathy, familial hypertrophic, 8 | Enrichment | MYL3 | 2.35 |
| 87 | Acne inversa, familial, 1 | Enrichment | NCSTN | 2.35 |
| 88 | Nephrotic syndrome, type 8 | Enrichment | ARHGDIA | 2.35 |
| 89 | Cardiomyopathy, dilated, 1ee | Enrichment | MYH6 | 2.35 |
| 90 | Sick sinus syndrome 3 | Enrichment | MYH6 | 2.35 |
| 91 | Developmental and epileptic encephalopathy 58 | Enrichment | NTRK2 | 2.35 |
| 92 | Deafness, autosomal dominant 4a | Enrichment | MYH14 | 2.35 |
| 93 | Congenital smooth muscle hamartoma, with or without hemihypertrophy | Enrichment | ACTB | 2.35 |
| 94 | Cardiomyopathy, dilated, 1v | Enrichment | PSEN2 | 2.35 |
| 95 | Atrial fibrillation, familial, 18 | Enrichment | MYL4 | 2.35 |
| 96 | Nemaline myopathy 7 | Enrichment | CFL2 | 2.35 |
| 97 | Becker nevus syndrome | Enrichment | ACTB | 2.35 |
| 98 | Dystonia-deafness syndrome 1 | Enrichment | ACTB | 2.35 |
| 99 | Cardiomyopathy, familial hypertrophic, 14 | Enrichment | MYH6 | 2.35 |
| 100 | Cardiomyopathy, dilated, 1u | Enrichment | PSEN1 | 2.35 |
| 101 | Glaucoma 1, open angle, o | Enrichment | NTF4 | 2.35 |
| 102 | Peripheral neuropathy, myopathy, hoarseness, and hearing loss | Enrichment | MYH14 | 2.35 |
| 103 | Acne inversa, familial, 2, with or without dowling-degos disease | Enrichment | PSENEN | 2.35 |
| 104 | Obesity, hyperphagia, and developmental delay | Enrichment | NTRK2 | 2.35 |
| 105 | Acne inversa, familial, 3 | Enrichment | PSEN1 | 2.35 |
| 106 | Intellectual developmental disorder, autosomal recessive 64 | Enrichment | LINGO1 | 2.35 |
| 107 | Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies | Enrichment | RHOA | 2.35 |
| 108 | Spastic paraplegia 75, autosomal recessive | Enrichment | MAG | 2.35 |
| 109 | Noonan syndrome-like disorder with loose anagen hair 2 | Enrichment | PPP1CB | 2.35 |
| 110 | Thrombocytopenia 8, with dysmorphic features and developmental delay | Enrichment | ACTB | 2.35 |
| 111 | Congenital myopathy 14 | Enrichment | MYL1 | 2.35 |
| 112 | Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies | Enrichment | RHOA | 2.35 |
| 113 | Baraitser-winter syndrome | Enrichment | ACTB | 2.35 |
| 114 | Autosomal dominant nonsyndromic hearing loss 17 | Enrichment | MYH9 | 2.35 |
| 115 | Congenital smooth muscle hamartoma | Enrichment | ACTB | 2.35 |
| 116 | Developmental malformations-deafness-dystonia syndrome | Enrichment | ACTB | 2.35 |
| 117 | Pash syndrome | Enrichment | NCSTN | 2.35 |
| 118 | Huntington's disease-like | Enrichment | PSEN2 | 2.35 |
| 119 | Thrombocytopenia 1 | Enrichment | WAS | 2.34 |
| 120 | Otopalatodigital syndrome, type i | Enrichment | FLNA | 2.34 |
| 121 | Intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked | Enrichment | FLNA | 2.34 |
| 122 | Congenital myopathy 2a, typical, autosomal dominant | Enrichment | ACTA1 | 2.34 |
| 123 | Amyotrophic lateral sclerosis 18 | Enrichment | PFN1 | 2.34 |
| 124 | Myopathy, scapulohumeroperoneal | Enrichment | ACTA1 | 2.34 |
| 125 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 | Enrichment | ACTG2 | 2.34 |
| 126 | Neurodevelopmental disorder with absent language and variable seizures | Enrichment | WASF1 | 2.34 |
| 127 | Terminal osseous dysplasia | Enrichment | FLNA | 2.34 |
| 128 | Intellectual developmental disorder with macrocephaly, seizures, and speech delay | Enrichment | PAK1 | 2.34 |
| 129 | Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia | Enrichment | ARPC1B | 2.34 |
| 130 | Fg syndrome 2 | Enrichment | FLNA | 2.34 |
| 131 | Otopalatodigital syndrome spectrum disorder | Enrichment | FLNA | 2.34 |
| 132 | Visceral neuropathy, familial, 3, autosomal dominant | Enrichment | ACTG2 | 2.34 |
| 133 | Congenital myopathy 2b, severe infantile, autosomal recessive | Enrichment | ACTA1 | 2.34 |
| 134 | Autosomal dominant familial visceral neuropathy | Enrichment | ACTG2 | 2.34 |
| 135 | Was-related disorders | Enrichment | WAS | 2.34 |
| 136 | X-linked ehlers-danlos syndrome | Enrichment | FLNA | 2.34 |
| 137 | Takenouchi-kosaki syndrome | Enrichment | CDC42 | 2.34 |
| 138 | Congenital myopathy 2c, severe infantile, autosomal dominant | Enrichment | ACTA1 | 2.34 |
| 139 | Zebra body myopathy | Enrichment | ACTA1 | 2.34 |
| 140 | Nocarh syndrome | Enrichment | CDC42 | 2.34 |
| 141 | X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome | Enrichment | FLNA | 2.34 |
| 142 | Actin-accumulation myopathy | Enrichment | ACTA1 | 2.34 |
| 143 | Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom | Enrichment | RAC1 | 2.34 |
| 144 | Myopathic intestinal pseudoobstruction | Enrichment | ACTG2 | 2.34 |
| 145 | Actg2 visceral myopathy | Enrichment | ACTG2 | 2.34 |
| 146 | Ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2 | 2.30 |
| 147 | Hypomagnesemia 3, renal | Enrichment | CLDN16 | 2.29 |
| 148 | Pseudo-torch syndrome 1 | Enrichment | OCLN | 2.29 |
| 149 | Cleft lip/palate-ectodermal dysplasia syndrome | Enrichment | NECTIN1 | 2.29 |
| 150 | Lipodystrophy, congenital generalized, type 3 | Enrichment | CAV1 | 2.29 |
| 151 | Deafness, autosomal dominant 51 | Enrichment | TJP2 | 2.29 |
| 152 | Pulmonary hypertension, primary, 3 | Enrichment | CAV1 | 2.29 |
| 153 | Pseudohypoaldosteronism, type iib | Enrichment | WNK4 | 2.29 |
| 154 | Ectodermal dysplasia 17 with or without limb malformations | Enrichment | LEF1 | 2.29 |
| 155 | Basal ganglia calcification, idiopathic, 8, autosomal recessive | Enrichment | JAM2 | 2.29 |
| 156 | Azoospermia, obstructive, with nephrolithiasis | Enrichment | CLDN2 | 2.29 |
| 157 | Orofacial cleft 7 | Enrichment | NECTIN1 | 2.29 |
| 158 | Lipodystrophy, familial partial, type 7 | Enrichment | CAV1 | 2.29 |
| 159 | Hemorrhagic destruction of the brain, subependymal calcification, and cataracts | Enrichment | JAM3 | 2.29 |
| 160 | Leukodystrophy, hypomyelinating, 22 | Enrichment | CLDN11 | 2.29 |
| 161 | Primary hypomagnesemia | Enrichment | CLDN16 | 2.29 |
| 162 | Sirenomelia | Enrichment | CDX2 | 2.29 |
| 163 | Anorectal malformation | Enrichment | CDX2 | 2.29 |
| 164 | Porencephaly-microcephaly-bilateral congenital cataract syndrome | Enrichment | JAM3 | 2.29 |
| 165 | Focal segmental glomerulosclerosis | Enrichment | COL4A4, COL4A5 | 2.26 |
| 166 | Stickler syndrome, type i | Enrichment | COL2A1 | 2.25 |
| 167 | Proteus syndrome | Enrichment | AKT1 | 2.25 |
| 168 | Epiphyseal dysplasia, multiple, with myopia and conductive deafness | Enrichment | COL2A1 | 2.25 |
| 169 | Hypoinsulinemic hypoglycemia with hemihypertrophy | Enrichment | AKT2 | 2.25 |
| 170 | Ehlers-danlos syndrome, cardiac valvular type | Enrichment | COL1A2 | 2.25 |
| 171 | Spondylometaphyseal dysplasia, algerian type | Enrichment | COL2A1 | 2.25 |
| 172 | Alport syndrome 1, x-linked | Enrichment | COL4A5 | 2.25 |
| 173 | Focal segmental glomerulosclerosis 1 | Enrichment | ACTN4 | 2.25 |
| 174 | Osteoarthritis with mild chondrodysplasia | Enrichment | COL2A1 | 2.25 |
| 175 | Avascular necrosis of femoral head, primary, 1 | Enrichment | COL2A1 | 2.25 |
| 176 | Noonan syndrome 5 | Enrichment | RAF1 | 2.25 |
| 177 | Czech dysplasia | Enrichment | COL2A1 | 2.25 |
| 178 | Noonan syndrome 4 | Enrichment | SOS1 | 2.25 |
| 179 | Cardiomyopathy, dilated, 1aa, with or without left ventricular noncompaction | Enrichment | ACTN2 | 2.25 |
| 180 | Melorheostosis, isolated | Enrichment | MAP2K1 | 2.25 |
| 181 | Kniest dysplasia | Enrichment | COL2A1 | 2.25 |
| 182 | Platyspondylic lethal skeletal dysplasia, torrance type | Enrichment | COL2A1 | 2.25 |
| 183 | Cardiomyopathy, dilated, 1nn | Enrichment | RAF1 | 2.25 |
| 184 | Cardiofaciocutaneous syndrome 3 | Enrichment | MAP2K1 | 2.25 |
| 185 | Noonan syndrome 9 | Enrichment | SOS2 | 2.25 |
| 186 | Spondyloepiphyseal dysplasia, stanescu type | Enrichment | COL2A1 | 2.25 |
| 187 | Lissencephaly 5 | Enrichment | LAMB1 | 2.25 |
| 188 | Achondrogenesis, type ii | Enrichment | COL2A1 | 2.25 |
| 189 | Noonan syndrome 13 | Enrichment | MAPK1 | 2.25 |
| 190 | Deafness, x-linked 6 | Enrichment | COL4A6 | 2.25 |
| 191 | Congenital myopathy 8 | Enrichment | ACTN2 | 2.25 |
| 192 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 2 | Enrichment | COL1A2 | 2.25 |
| 193 | Spondyloperipheral dysplasia | Enrichment | COL2A1 | 2.25 |
| 194 | Porencephaly | Enrichment | COL4A1 | 2.25 |
| 195 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 | Enrichment | AKT3 | 2.25 |
| 196 | Cardiomyopathy, dilated, 1w | Enrichment | VCL | 2.25 |
| 197 | Actn3 deficiency | Enrichment | ACTN3 | 2.25 |
| 198 | Melorheostosis | Enrichment | MAP2K1 | 2.25 |
| 199 | Stickler syndrome, type i, nonsyndromic ocular | Enrichment | COL2A1 | 2.25 |
| 200 | Leopard syndrome 2 | Enrichment | RAF1 | 2.25 |
| 201 | Cardiomyopathy, familial hypertrophic, 15 | Enrichment | VCL | 2.25 |
| 202 | Cardiofaciocutaneous syndrome 4 | Enrichment | MAP2K2 | 2.25 |
| 203 | Cowden syndrome 6 | Enrichment | AKT1 | 2.25 |
| 204 | Bleeding disorder, platelet-type, 15 | Enrichment | ACTN1 | 2.25 |
| 205 | Thrombocytopenia 6 | Enrichment | SRC | 2.25 |
| 206 | Myopathy, distal, 6, adult-onset, autosomal dominant | Enrichment | ACTN2 | 2.25 |
| 207 | Intellectual developmental disorder, autosomal dominant 63, with macrocephaly | Enrichment | TRIO | 2.25 |
| 208 | Trigonitis | Enrichment | RAF1 | 2.25 |
| 209 | Vitreoretinopathy with phalangeal epiphyseal dysplasia | Enrichment | COL2A1 | 2.25 |
| 210 | Asphyxia neonatorum | Enrichment | COL1A1 | 2.25 |
| 211 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 2.25 |
| 212 | Col4a1-related disorders | Enrichment | COL4A1 | 2.25 |
| 213 | Capillary hemangioma | Enrichment | AKT3 | 2.25 |
| 214 | Autosomal dominant rhegmatogenous retinal detachment | Enrichment | COL2A1 | 2.25 |
| 215 | Fetomaternal alloimmune thrombocytopenia 3 | Enrichment | ITGA2 | 2.25 |
| 216 | Col4a1 or col4a2-related cerebral small vessel disease | Enrichment | COL4A1 | 2.25 |
| 217 | Multiple epiphyseal dysplasia with myopia and deafness | Enrichment | COL2A1 | 2.25 |
| 218 | Immune dysregulation, neurodevelopmental defects, and colitis | Enrichment | ITGAV | 2.25 |
| 219 | Hypochondrogenesis | Enrichment | COL2A1 | 2.25 |
| 220 | Capillary leak syndrome | Enrichment | TLN1 | 2.25 |
| 221 | X-linked alport syndrome | Enrichment | COL4A5 | 2.25 |
| 222 | Dysspondyloenchondromatosis | Enrichment | COL2A1 | 2.25 |
| 223 | Phakomatosis pigmentokeratotica | Enrichment | HRAS | 2.25 |
| 224 | Type 2 collagen-related bone disorder | Enrichment | COL2A1 | 2.25 |
| 225 | Microcystic stromal tumor | Enrichment | CTNNB1 | 2.25 |
| 226 | Akt2-related familial partial lipodystrophy | Enrichment | AKT2 | 2.25 |
| 227 | Temporomandibular joint anomaly | Enrichment | DOCK1 | 2.16 |
| 228 | Differentiated thyroid carcinoma | Enrichment | NTRK1, NTRK3 | 2.14 |
| 229 | Brittle bone disorder | Enrichment | COL1A1, COL1A2 | 2.14 |
| 230 | Aortic aneurysm, familial thoracic 4 | Enrichment | MYH11 | 2.05 |
| 231 | Arthrogryposis, distal, type 2a | Enrichment | MYH3 | 2.05 |
| 232 | Insensitivity to pain, congenital, with anhidrosis | Enrichment | NTRK1 | 2.05 |
| 233 | Ebstein anomaly | Enrichment | MYH7 | 2.05 |
| 234 | Cataract 35 | Enrichment | MYH9 | 2.05 |
| 235 | Alzheimer disease 3 | Enrichment | PSEN1 | 2.05 |
| 236 | Pick disease of brain | Enrichment | PSEN1 | 2.05 |
| 237 | Arthrogryposis, distal, type 7 | Enrichment | MYH8 | 2.05 |
| 238 | Deafness, autosomal dominant 20 | Enrichment | ACTG1 | 2.05 |
| 239 | Baraitser-winter syndrome 2 | Enrichment | ACTG1 | 2.05 |
| 240 | Pain sensitivity quantitative trait locus 1 | Enrichment | NTRK1 | 2.05 |
| 241 | Arthrogryposis, distal, type 2b3 | Enrichment | MYH3 | 2.05 |
| 242 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 | Enrichment | MYH11 | 2.05 |
| 243 | Genitourinary and/or brain malformation syndrome | Enrichment | PPP1R12A | 2.05 |
| 244 | Atrial septal defect 3 | Enrichment | MYH6 | 2.05 |
| 245 | Noonan syndrome-like disorder with loose anagen hair | Enrichment | PPP1CB | 2.05 |
| 246 | Cardiomyopathy, familial hypertrophic, 10 | Enrichment | MYL2 | 2.05 |
| 247 | Congenital mesoblastic nephroma | Enrichment | NTRK3 | 2.05 |
| 248 | Inflammatory skin and bowel disease, neonatal, 1 | Enrichment | ADAM17 | 2.05 |
| 249 | Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome | Enrichment | MYH2 | 2.05 |
| 250 | Pseudosarcomatous fibromatosis | Enrichment | MYH9 | 2.05 |
| 251 | Fibrosarcoma | Enrichment | NTRK3 | 2.05 |
| 252 | Visceral myopathy 2 | Enrichment | MYH11 | 2.05 |
| 253 | Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy | Enrichment | MYL2 | 2.05 |
| 254 | Arthrogryposis, distal, type 1c | Enrichment | MYL11 | 2.05 |
| 255 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 4 | Enrichment | MYL9 | 2.05 |
| 256 | Childhood-onset autosomal recessive myopathy with external ophthalmoplegia | Enrichment | MYH2 | 2.05 |
| 257 | Carney complex - trismus - pseudocamptodactyly syndrome | Enrichment | MYH8 | 2.05 |
| 258 | Visceral neuropathy, familial, 1, autosomal recessive | Enrichment | FLNA | 2.04 |
| 259 | Neutropenia, severe congenital, x-linked | Enrichment | WAS | 2.04 |
| 260 | Otopalatodigital syndrome, type ii | Enrichment | FLNA | 2.04 |
| 261 | Melnick-needles syndrome | Enrichment | FLNA | 2.04 |
| 262 | Wiskott-aldrich syndrome | Enrichment | WAS | 2.04 |
| 263 | Frontometaphyseal dysplasia 1 | Enrichment | FLNA | 2.04 |
| 264 | Aortic aneurysm, familial thoracic 2 | Enrichment | ACTA2 | 2.04 |
| 265 | Cardiomyopathy, dilated, 1r | Enrichment | ACTC1 | 2.04 |
| 266 | Cardiomyopathy, familial hypertrophic, 11 | Enrichment | ACTC1 | 2.04 |
| 267 | Smooth muscle dysfunction syndrome | Enrichment | ACTA2 | 2.04 |
| 268 | Aortic aneurysm, familial thoracic 6 | Enrichment | ACTA2 | 2.04 |
| 269 | Moyamoya disease 5 | Enrichment | ACTA2 | 2.04 |
| 270 | Atrial septal defect 5 | Enrichment | ACTC1 | 2.04 |
| 271 | Intellectual developmental disorder, autosomal dominant 48 | Enrichment | RAC1 | 2.04 |
| 272 | Developmental delay, language impairment, and ocular abnormalities | Enrichment | ARPC4 | 2.04 |
| 273 | Cardiac valvular dysplasia, x-linked | Enrichment | FLNA | 2.04 |
| 274 | Immunodeficiency 113 with autoimmunity and autoinflammation | Enrichment | ARPC5 | 2.04 |
| 275 | Immune system disease | Enrichment | CDC42 | 2.04 |
| 276 | Immunodeficiency 133 | Enrichment | ARPC5 | 2.04 |
| 277 | Intestinal obstruction | Enrichment | ACTG2 | 2.04 |
| 278 | Ectrodactyly and ectodermal dysplasia without cleft lip/palate | Enrichment | LEF1 | 1.99 |
| 279 | Cholestasis, progressive familial intrahepatic, 4 | Enrichment | TJP2 | 1.99 |
| 280 | Split hand-foot malformation | Enrichment | LEF1 | 1.99 |
| 281 | Choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction | Enrichment | NKX2-1 | 1.99 |
| 282 | Deafness, autosomal recessive 29 | Enrichment | CLDN14 | 1.99 |
| 283 | Nkx2-1-related disorders | Enrichment | NKX2-1 | 1.99 |
| 284 | Non-syndromic genetic deafness | Enrichment | ACTG1, MYH14 | 1.96 |
| 285 | Left ventricular noncompaction | Enrichment | ACTC1, MYH7 | 1.95 |
| 286 | Epiphyseal dysplasia, multiple, 1 | Enrichment | COL1A1 | 1.95 |
| 287 | Fibromatosis, gingival, 1 | Enrichment | SOS1 | 1.95 |
| 288 | Costello syndrome | Enrichment | HRAS | 1.95 |
| 289 | Bruck syndrome 1 | Enrichment | COL1A2 | 1.95 |
| 290 | Otospondylomegaepiphyseal dysplasia, autosomal recessive | Enrichment | COL2A1 | 1.95 |
| 291 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 1.95 |
| 292 | Dermatofibrosarcoma protuberans | Enrichment | COL1A1 | 1.95 |
| 293 | Pulmonic stenosis | Enrichment | SOS1 | 1.95 |
| 294 | Lethal congenital contracture syndrome 3 | Enrichment | PIP5K1C | 1.95 |
| 295 | Legg-calve-perthes disease | Enrichment | COL2A1 | 1.95 |
| 296 | Deafness, autosomal recessive 28 | Enrichment | TRIO | 1.95 |
| 297 | Lissencephaly 1 | Enrichment | LAMB1 | 1.95 |
| 298 | Specific language impairment 5 | Enrichment | COL4A4 | 1.95 |
| 299 | Otospondylomegaepiphyseal dysplasia, autosomal dominant | Enrichment | COL2A1 | 1.95 |
| 300 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | Enrichment | COL4A2 | 1.95 |
| 301 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 1 | Enrichment | COL1A1 | 1.95 |
| 302 | Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome | Enrichment | ITGA3 | 1.95 |
| 303 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1 | 1.95 |
| 304 | Senior-loken syndrome 7 | Enrichment | AKT3 | 1.95 |
| 305 | Glomerulonephritis | Enrichment | COL4A4 | 1.95 |
| 306 | Stickler syndrome, type ii | Enrichment | COL1A1 | 1.95 |
| 307 | Familial avascular necrosis of the femoral head | Enrichment | COL2A1 | 1.95 |
| 308 | Bardet-biedl syndrome 16 | Enrichment | AKT3 | 1.95 |
| 309 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 1.95 |
| 310 | Dentinogenesis imperfecta | Enrichment | COL1A2 | 1.95 |
| 311 | Teratoma | Enrichment | CTNNB1 | 1.95 |
| 312 | Tafro syndrome | Enrichment | MAP2K2 | 1.95 |
| 313 | Wooly hair nevus | Enrichment | HRAS | 1.95 |
| 314 | Bladder cancer | Enrichment | CTNNB1, HRAS | 1.94 |
| 315 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | Enrichment | MYH9 | 1.88 |
| 316 | Thyroid carcinoma, familial medullary | Enrichment | NTRK1 | 1.88 |
| 317 | Spondylocarpotarsal synostosis syndrome | Enrichment | MYH3 | 1.88 |
| 318 | Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy | Enrichment | MYH15 | 1.88 |
| 319 | Qualitative or quantitative defects of beta-myosin heavy chain | Enrichment | MYH7 | 1.88 |
| 320 | Idiopathic camptocormia | Enrichment | MYH7 | 1.88 |
| 321 | Neonatal inflammatory skin and bowel disease | Enrichment | ADAM17 | 1.88 |
| 322 | Tricuspid valve insufficiency | Enrichment | MYH11 | 1.88 |
| 323 | Prune belly syndrome | Enrichment | FLNA | 1.86 |
| 324 | Arterial tortuosity syndrome | Enrichment | FLNA | 1.86 |
| 325 | Periventricular nodular heterotopia 1 | Enrichment | FLNA | 1.86 |
| 326 | Aortic aneurysm, familial thoracic 7 | Enrichment | MYLK | 1.86 |
| 327 | Congenital short bowel syndrome | Enrichment | FLNA | 1.86 |
| 328 | Frontometaphyseal dysplasia | Enrichment | FLNA | 1.86 |
| 329 | Nonsyndromic hearing loss | Enrichment | ACTG1, MYH14 | 1.83 |
| 330 | Hypercholanemia, familial 1 | Enrichment | TJP2 | 1.82 |
| 331 | Thrombocytopenia 5 | Enrichment | CLDN16 | 1.82 |
| 332 | Cakut | Enrichment | ACTG1, COL4A1 | 1.81 |
| 333 | Genetic steroid-resistant nephrotic syndrome | Enrichment | ACTN4, COL4A3 | 1.81 |
| 334 | Desmoid disease, hereditary | Enrichment | CTNNB1 | 1.78 |
| 335 | Hyper-ige syndrome 1, autosomal dominant, with recurrent infections | Enrichment | ITGB3 | 1.78 |
| 336 | Mccune-albright syndrome | Enrichment | COL2A1 | 1.78 |
| 337 | Retinal arteries, tortuosity of | Enrichment | COL4A1 | 1.78 |
| 338 | Spondyloepiphyseal dysplasia congenita | Enrichment | COL2A1 | 1.78 |
| 339 | Bleeding disorder, platelet-type, 16 | Enrichment | ITGB3 | 1.78 |
| 340 | Glomerulopathy with fibronectin deposits 2 | Enrichment | FN1 | 1.78 |
| 341 | Nuchal bleb, familial | Enrichment | SOS1 | 1.78 |
| 342 | Langerhans cell histiocytosis | Enrichment | MAP2K1 | 1.78 |
| 343 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 1.78 |
| 344 | Caffey disease | Enrichment | COL1A1 | 1.78 |
| 345 | Brain small vessel disease 2 | Enrichment | COL4A2 | 1.78 |
| 346 | Anus, imperforate | Enrichment | CTNNB1 | 1.78 |
| 347 | Microangiopathy and leukoencephalopathy, pontine, autosomal dominant | Enrichment | COL4A1 | 1.78 |
| 348 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 1.78 |
| 349 | Pilarowski-bjornsson syndrome | Enrichment | COL4A3 | 1.78 |
| 350 | Alport syndrome 3b, autosomal recessive | Enrichment | COL4A3 | 1.78 |
| 351 | Large congenital melanocytic nevus | Enrichment | HRAS | 1.78 |
| 352 | Desmoid tumor | Enrichment | CTNNB1 | 1.78 |
| 353 | Poretti-boltshauser syndrome | Enrichment | LAMA1 | 1.78 |
| 354 | Intellectual developmental disorder, autosomal dominant 44, with microcephaly | Enrichment | TRIO | 1.78 |
| 355 | Intrinsic cardiomyopathy | Enrichment | ACTN2 | 1.78 |
| 356 | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps | Enrichment | COL4A1 | 1.78 |
| 357 | Hematuria, benign familial, 2 | Enrichment | COL4A3 | 1.78 |
| 358 | Spermatocytoma | Enrichment | HRAS | 1.78 |
| 359 | Bleeding disorder, platelet-type, 24 | Enrichment | ITGB3 | 1.78 |
| 360 | Multiple epiphyseal dysplasia | Enrichment | COL2A1 | 1.78 |
| 361 | Rare genetic deafness | Enrichment | ACTG1, COL4A5, MYH9 | 1.77 |
| 362 | Myopathy, distal, 1 | Enrichment | MYH7 | 1.76 |
| 363 | Congenital myopathy 7b, myosin storage, autosomal recessive | Enrichment | MYH7 | 1.76 |
| 364 | Carney complex variant | Enrichment | MYH8 | 1.76 |
| 365 | Congenital myopathy 7a, myosin storage, autosomal dominant | Enrichment | MYH7 | 1.76 |
| 366 | Congenital myopathy 6 with ophthalmoplegia | Enrichment | MYH2 | 1.76 |
| 367 | Aminoacylase 1 deficiency | Enrichment | ACTB | 1.76 |
| 368 | Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1b | Enrichment | MYH3 | 1.76 |
| 369 | Dowling-degos disease | Enrichment | PSENEN | 1.76 |
| 370 | Hyaline body myopathy | Enrichment | MYH7 | 1.76 |
| 371 | Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) | Enrichment | MYH11 | 1.76 |
| 372 | Mitral valve insufficiency | Enrichment | MYH11 | 1.76 |
| 373 | Glioma | Enrichment | NTRK3 | 1.76 |
| 374 | Familial sick sinus syndrome | Enrichment | MYH6 | 1.76 |
| 375 | Pseudomyogenic hemangioendothelioma | Enrichment | ACTB | 1.76 |
| 376 | Nemaline myopathy 2 | Enrichment | ACTA1 | 1.74 |
| 377 | Autoimmune lymphoproliferative syndrome | Enrichment | ACTA2 | 1.74 |
| 378 | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia | Enrichment | CDC42 | 1.74 |
| 379 | Intermediate nemaline myopathy | Enrichment | ACTA1 | 1.74 |
| 380 | Cerebral palsy | Enrichment | COL4A1, COL4A2 | 1.70 |
| 381 | Chorea, benign hereditary | Enrichment | NKX2-1 | 1.69 |
| 382 | Thyroid cancer, nonmedullary, 1 | Enrichment | NKX2-1 | 1.69 |
| 383 | Hereditary ataxia | Enrichment | NKX2-1 | 1.69 |
| 384 | Hydrocephalus, congenital, 2, with or without brain or eye anomalies | Enrichment | MPDZ | 1.69 |
| 385 | Cleft lip and alveolus | Enrichment | NECTIN1 | 1.69 |
| 386 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | Enrichment | ITGA7 | 1.69 |
| 387 | Body mass index quantitative trait locus 11 | Enrichment | BDNF, MYH9 | 1.69 |
| 388 | Arthrogryposis, distal, type 2b1 | Enrichment | MYH3 | 1.66 |
| 389 | Deafness, autosomal recessive 63 | Enrichment | MYH9 | 1.66 |
| 390 | Congenital ptosis | Enrichment | MYH10 | 1.66 |
| 391 | Dementia | Enrichment | PSEN1 | 1.66 |
| 392 | Coloboma of choroid and retina | Enrichment | ACTG1 | 1.66 |
| 393 | Schimmelpenning-feuerstein-mims syndrome | Enrichment | HRAS | 1.65 |
| 394 | Phenylketonuria | Enrichment | COL1A1 | 1.65 |
| 395 | Schizencephaly | Enrichment | COL4A1 | 1.65 |
| 396 | Neurofibromatosis-noonan syndrome | Enrichment | MAP2K2 | 1.65 |
| 397 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | AKT3 | 1.65 |
| 398 | Chromosome 22q11.2 deletion syndrome, distal | Enrichment | MAPK1 | 1.65 |
| 399 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 | Enrichment | AKT3 | 1.65 |
| 400 | Pilomatrixoma | Enrichment | CTNNB1 | 1.65 |
| 401 | Alazami syndrome | Enrichment | CTNNB1 | 1.65 |
| 402 | Mantle cell lymphoma | Enrichment | CCND1 | 1.65 |
| 403 | Craniopharyngioma | Enrichment | CTNNB1 | 1.65 |
| 404 | Noonan syndrome with multiple lentigines | Enrichment | RAF1 | 1.65 |
| 405 | Epidermolytic nevus | Enrichment | HRAS | 1.65 |
| 406 | Rare x-linked non-syndromic sensorineural deafness type dfn | Enrichment | COL4A6 | 1.65 |
| 407 | Gingival fibromatosis | Enrichment | SOS1 | 1.65 |
| 408 | Male infertility due to gonadal dysgenesis or sperm disorder | Enrichment | SOS2 | 1.65 |
| 409 | Severe congenital nemaline myopathy | Enrichment | ACTA1 | 1.64 |
| 410 | Type 2 diabetes mellitus | Enrichment | AKT2, TCF7L2 | 1.64 |
| 411 | Cleft upper lip | Enrichment | NECTIN1 | 1.60 |
| 412 | Diffuse cutaneous systemic sclerosis | Enrichment | CAV1 | 1.60 |
| 413 | Undetermined early-onset epileptic encephalopathy | Enrichment | LIMK1, NTRK2 | 1.59 |
| 414 | Telangiectasia, hereditary hemorrhagic, type 1 | Enrichment | PSEN1 | 1.58 |
| 415 | Hemihyperplasia, isolated | Enrichment | RHOA | 1.58 |
| 416 | Wilms tumor, aniridia, genitourinary anomalies, and impaired intellectual development syndrome | Enrichment | BDNF | 1.58 |
| 417 | Hemangioma, capillary infantile | Enrichment | MYH9 | 1.58 |
| 418 | Inherited arrhythmogenic cardiomyopathy | Enrichment | MYH7 | 1.58 |
| 419 | Moyamoya disease 1 | Enrichment | ACTA2 | 1.57 |
| 420 | Patent ductus arteriosus | Enrichment | FLNA | 1.57 |
| 421 | Retinal detachment | Enrichment | COL2A1 | 1.56 |
| 422 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1 | 1.56 |
| 423 | Von hippel-lindau syndrome | Enrichment | CCND1 | 1.56 |
| 424 | Glanzmann thrombasthenia 2 | Enrichment | ITGB3 | 1.56 |
| 425 | Hemimegalencephaly | Enrichment | AKT3 | 1.56 |
| 426 | Branchiootorenal syndrome 1 | Enrichment | TJP2 | 1.52 |
| 427 | Split-hand/foot malformation 1 | Enrichment | LEF1 | 1.52 |
| 428 | Limited scleroderma | Enrichment | CAV1 | 1.52 |
| 429 | Familial hypercholanemia | Enrichment | TJP2 | 1.52 |
| 430 | Semantic dementia | Enrichment | PSEN1 | 1.51 |
| 431 | Pilomyxoid astrocytoma | Enrichment | NTRK2 | 1.51 |
| 432 | Familial isolated restrictive cardiomyopathy | Enrichment | MYL2 | 1.51 |
| 433 | Childhood-onset nemaline myopathy | Enrichment | ACTA1 | 1.50 |
| 434 | Developmental dysplasia of the hip 1 | Enrichment | COL2A1 | 1.48 |
| 435 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 1.48 |
| 436 | Adrenocortical carcinoma | Enrichment | CTNNB1 | 1.48 |
| 437 | Breast adenocarcinoma | Enrichment | AKT1 | 1.48 |
| 438 | Martsolf syndrome 1 | Enrichment | ARHGAP35 | 1.47 |
| 439 | Arthrogryposis, distal, type 1a | Enrichment | MYH3 | 1.46 |
| 440 | Myocarditis | Enrichment | MYH7 | 1.46 |
| 441 | Hypoplastic left heart syndrome | Enrichment | MYH6 | 1.46 |
| 442 | Hypothyroidism, congenital, nongoitrous, 2 | Enrichment | NKX2-1 | 1.45 |
| 443 | Branchiootorenal syndrome | Enrichment | TJP2 | 1.45 |
| 444 | Congenital hydrocephalus | Enrichment | MPDZ | 1.45 |
| 445 | Fanconi anemia, complementation group c | Enrichment | FLNA | 1.44 |
| 446 | Nevus, epidermal | Enrichment | HRAS | 1.41 |
| 447 | Thyroid cancer, nonmedullary, 2 | Enrichment | HRAS | 1.41 |
| 448 | Myelofibrosis | Enrichment | SRC | 1.41 |
| 449 | Glanzmann thrombasthenia 1 | Enrichment | ITGB3 | 1.41 |
| 450 | Capillary malformation-arteriovenous malformation 1 | Enrichment | MAP2K1 | 1.41 |
| 451 | Multiple enchondromatosis, maffucci type | Enrichment | COL2A1 | 1.41 |
| 452 | Gallbladder cancer | Enrichment | CTNNB1 | 1.41 |
| 453 | Megacolon | Enrichment | AKT3 | 1.41 |
| 454 | Follicular thyroid carcinoma | Enrichment | HRAS | 1.41 |
| 455 | Cardiomyopathy, familial hypertrophic, 4 | Enrichment | MYH7 | 1.41 |
| 456 | Congenital central hypoventilation syndrome | Enrichment | BDNF | 1.41 |
| 457 | Progressive non-fluent aphasia | Enrichment | PSEN1 | 1.41 |
| 458 | Familial isolated arrhythmogenic right ventricular dysplasia | Enrichment | MYH7 | 1.41 |
| 459 | Behavioral variant of frontotemporal dementia | Enrichment | PSEN1 | 1.41 |
| 460 | Basal ganglia calcification, idiopathic, 1 | Enrichment | JAM2 | 1.40 |
| 461 | Perrault syndrome | Enrichment | CLDN14 | 1.40 |
| 462 | Choreatic disease | Enrichment | NKX2-1 | 1.40 |
| 463 | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies | Enrichment | RAC1 | 1.39 |
| 464 | Deafness, autosomal recessive | Enrichment | CLDN14, MYH9 | 1.39 |
| 465 | Autosomal recessive nonsyndromic deafness | Enrichment | CLDN14, MYH9 | 1.38 |
| 466 | Cat eye syndrome | Enrichment | ACTG1 | 1.36 |
| 467 | Renal hypodysplasia/aplasia 1 | Enrichment | ITGA8 | 1.36 |
| 468 | Exudative vitreoretinopathy | Enrichment | CTNNB1 | 1.36 |
| 469 | Nemaline myopathy | Enrichment | ACTA1 | 1.35 |
| 470 | Primary biliary cholangitis | Enrichment | TJP2 | 1.35 |
| 471 | Frontotemporal dementia 1 | Enrichment | PSEN1 | 1.32 |
| 472 | Combined immunodeficiency | Enrichment | ARPC1B | 1.31 |
| 473 | Combined t cell and b cell immunodeficiency | Enrichment | ARPC1B | 1.31 |
| 474 | Combined t and b cell immunodeficiency | Enrichment | ARPC1B | 1.31 |
| 475 | Adult hepatocellular carcinoma | Enrichment | CTNNB1 | 1.31 |
| 476 | Cowden syndrome | Enrichment | AKT1 | 1.31 |
| 477 | Renal agenesis, bilateral | Enrichment | ITGA8 | 1.31 |
| 478 | Hypertelorism | Enrichment | COL1A1, MYH10 | 1.31 |
| 479 | Restrictive cardiomyopathy | Enrichment | MYH7 | 1.29 |
| 480 | Heritable pulmonary arterial hypertension | Enrichment | CAV1 | 1.26 |
| 481 | Marfan syndrome | Enrichment | COL2A1 | 1.26 |
| 482 | Leukemia, chronic lymphocytic | Enrichment | CCND1 | 1.26 |
| 483 | Stickler syndrome | Enrichment | COL2A1 | 1.26 |
| 484 | Polymicrogyria | Enrichment | AKT3 | 1.26 |
| 485 | Microphthalmia/coloboma 12 | Enrichment | MYH10 | 1.25 |
| 486 | Alzheimer's disease | Enrichment | PSEN1 | 1.25 |
| 487 | Specific learning disability | Enrichment | MAPK1 | 1.22 |
| 488 | Heart disease | Enrichment | MYL2 | 1.22 |
| 489 | Lung cancer susceptibility 3 | Enrichment | ACTA2 | 1.21 |
| 490 | Periventricular nodular heterotopia | Enrichment | FLNA | 1.21 |
| 491 | Neural tube defects | Enrichment | ITGB1 | 1.19 |
| 492 | Coloboma of macula | Enrichment | MYH10 | 1.19 |
| 493 | Meningioma | Enrichment | AKT1 | 1.19 |
| 494 | Lip and oral cavity carcinoma | Enrichment | HRAS | 1.19 |
| 495 | Breast cancer | Enrichment | AKT1, JUN | 1.18 |
| 496 | Wolff-parkinson-white syndrome | Enrichment | MYH7 | 1.16 |
| 497 | Cleft lip/palate | Enrichment | NECTIN1 | 1.16 |
| 498 | Aortic valve disease 1 | Enrichment | SOS1 | 1.15 |
| 499 | Alzheimer disease, familial, 1 | Enrichment | PSEN1 | 1.14 |
| 500 | Dandy-walker syndrome | Enrichment | PPP1CB | 1.14 |
| 501 | Cleft palate, isolated | Enrichment | FLNA | 1.13 |
| 502 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | CLDN14, MYH9 | 1.12 |
| 503 | Multiple sclerosis | Enrichment | LAMB1 | 1.12 |
| 504 | Medulloblastoma | Enrichment | CTNNB1 | 1.12 |
| 505 | Walker-warburg syndrome | Enrichment | COL4A1 | 1.12 |
| 506 | 46,xy partial gonadal dysgenesis | Enrichment | SOS1 | 1.12 |
| 507 | Isolated macular dystrophy | Enrichment | COL4A5 | 1.12 |
| 508 | Isolated congenital microcephaly | Enrichment | OCLN | 1.11 |
| 509 | Corpus callosum, agenesis of | Enrichment | COL4A1 | 1.09 |
| 510 | Anterior segment dysgenesis | Enrichment | COL4A1 | 1.09 |
| 511 | Atypical hemolytic-uremic syndrome | Enrichment | COL4A5 | 1.09 |
| 512 | Isolated corpus callosum agenesis | Enrichment | COL4A1 | 1.09 |
| 513 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | COL4A1 | 1.09 |
| 514 | Williams-beuren syndrome | Enrichment | LIMK1 | 1.07 |
| 515 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | ACTN2 | 1.07 |
| 516 | Rhabdomyosarcoma | Enrichment | HRAS | 1.07 |
| 517 | Lissencephaly | Enrichment | ACTG1 | 1.05 |
| 518 | Polycystic liver disease | Enrichment | CTNNB1 | 1.04 |
| 519 | Syndromic intellectual disability | Enrichment | TRIO | 1.04 |
| 520 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1 | 1.04 |
| 521 | Skin disease | Enrichment | NCSTN | 1.03 |
| 522 | Polycystic kidney disease | Enrichment | COL4A4 | 1.02 |
| 523 | Familial atrial fibrillation | Enrichment | MYL4 | 1.00 |
| 524 | Ovarian cancer | Enrichment | AKT1, CTNNB1 | 0.96 |
| 525 | Complex neurodevelopmental disorder | Enrichment | MYH10, WASF1 | 0.96 |
| 526 | Hepatoblastoma | Enrichment | CTNNB1 | 0.95 |
| 527 | Hydrops fetalis, nonimmune | Enrichment | ACTA1 | 0.95 |
| 528 | Hepatocellular carcinoma | Enrichment | CTNNB1 | 0.93 |
| 529 | Myocardial infarction | Enrichment | ITGB3 | 0.93 |
| 530 | Scoliosis | Enrichment | COL2A1 | 0.90 |
| 531 | Long qt syndrome | Enrichment | MYH6 | 0.89 |
| 532 | Peripheral nervous system disease | Enrichment | NGF | 0.88 |
| 533 | Neuropathy | Enrichment | NGF | 0.88 |
| 534 | Non-immune hydrops fetalis | Enrichment | ACTA1 | 0.88 |
| 535 | Lung cancer | Enrichment | ACTA2 | 0.86 |
| 536 | Connective tissue disease | Enrichment | ACTA2 | 0.86 |
| 537 | Severe covid-19 | Enrichment | ITGAV | 0.82 |
| 538 | Stargardt disease 1 | Enrichment | COL2A1 | 0.81 |
| 539 | Fetal akinesia deformation sequence 1 | Enrichment | ACTA1 | 0.81 |
| 540 | Male infertility | Enrichment | CLDN2 | 0.80 |
| 541 | West syndrome | Enrichment | NTRK2 | 0.75 |
| 542 | Sensorineural hearing loss | Enrichment | CLDN14 | 0.66 |
| 543 | Hereditary breast carcinoma | Enrichment | AKT1 | 0.66 |
| 544 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | PSEN1 | 0.64 |
| 545 | Schizophrenia | Enrichment | RTN4R | 0.64 |
| 546 | Primary ovarian insufficiency | Enrichment | NTRK1 | 0.64 |
| 547 | Myeloma, multiple | Enrichment | NKX2-1 | 0.60 |
| 548 | Autism | Enrichment | TCF7L2 | 0.51 |
| 549 | Hereditary breast ovarian cancer syndrome | Enrichment | BCAR1 | 0.50 |
| 550 | Congenital nervous system abnormality | Enrichment | PSEN1 | 0.42 |
| 551 | Nervous system disease | Enrichment | PSEN1 | 0.42 |
| 552 | Autism spectrum disorder | Enrichment | MAP2K1 | 0.34 |
| 553 | Hereditary retinal dystrophy | Enrichment | COL2A1, LAMA1 | 0.31 |
| 554 | Fundus dystrophy | Enrichment | COL2A1, LAMA1 | 0.31 |